Ramucirumab effective in patients with advanced HCC and AFP ≥400 ng/mL after non-sorafenib therapiesOctober 24, 2022Hepatocellular Carcinoma
Unresectable HCC: Atezolizumab plus bevacizumab proves its worth in the clinicOctober 24, 2022Hepatocellular Carcinoma
Ulcerative colitis: Reassuring findings on long-term tofacitinib reportedOctober 24, 2022IBD & Intestinal Disorders
New report: Physician views on race, ethnicity, and diversity in gastroenterologyOctober 21, 2022Society News
Children with asymptomatic celiac disease may have severe disease histologyOctober 20, 2022IBD & Intestinal Disorders
FMT in IBS: ‘We’ve been targeting the wrong part of the intestine’October 20, 2022IBD & Intestinal Disorders
One-third of pancreatic cancer diagnoses missed on scansOctober 18, 2022GI OncologyPancreas and Biliary Tract
Vedolizumab linked to increased treatment failure in older patients with Crohn’sOctober 17, 2022IBD & Intestinal Disorders
Patients differ with providers on definitions for IBD remissionOctober 17, 2022IBD & Intestinal Disorders
